Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 83, 2023 - Issue 2
Submit an article Journal homepage
1,445
Views
1
CrossRef citations to date
0
Altmetric
Note

Analytical evaluation and quality assessment of the ARKRAY ADAMS A1c HA-8190V for Hb A1c

Eloísa UrrechagaHematology Laboratory, Hospital Galdakao – Usansolo, Galdakao, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9610-7392
ORCID Icon
Pages 136-142 | Received 23 Jun 2022, Accepted 08 Jan 2023, Published online: 18 Jan 2023

References

  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
  • The International Expert Committee. International Expert Committee Report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–1334.
  • Urrechaga E. Analytical evaluation of the ADAMS ™ A1c HA-8180 thalassemia mode analyser for the measurement of HbA1c. J Clin Lab Anal. 2018;32(1):e22155.
  • Weykamp C, Lenters-Westra E, van der Vuurst H, et al. Evaluation of the menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c. Clin Chem Lab Med. 2011;49(4):647–651.
  • CLSI. User verification of precision and estimation of bias; approved guideline. 3rd ed. (CLSI document EP5-A3). Wayne (PA): clinical and Laboratory Standards Institute; 2014.
  • Jeppsson J-O, Kobold U, Barr J, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40(1):78–89.
  • CLSI. Preliminary evaluation of quantitative clinical laboratory measurement procedures; approved guideline. 3rd ed. (CLSI document EP10-A3-AMD). Wayne (PA): Clinical and Laboratory Standards Institute; 2014.
  • CLSI. Evaluation of the linearity of quantitative measurement procedure: a statistical approach; approved guideline (CLSI document EP06-A). Wayne (PA): Clinical and Laboratory Standards Institute; 2003.
  • Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Biochem. 1983;21(11):709–720.
  • Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurements. Lancet. 1986;1:307–310.
  • Weykamp C, Siebelder C. Evaluation of performance of laboratories and manufacturers within the framework of the IFCC model for quality targets of HbA1c. J Diabetes Sci Technol. 2018;12(4):747–752.
  • Urrechaga E. Evaluation of ADAMS ™ A1c HA-8180V HPLC analyzer for HbA1c determination. JLife SciUSA. 2012;6:456–460.
  • van der Hagen EAE, Leppink S, Bokker K, et al. Evaluation of the ARKRAY HA-8190V instrument for HbA1c. Clin Chem Lab Med. 2021;59(5):965–970.
  • Renata Paleari R, Mosca F, A, Ceriotti. Performance evaluation of ARKRAY HA-8190V system for measuring glycated hemoglobin. Biochim Clin. 2022;46:68–73.
  • Ricós C, Iglesias N, Garcia-Lario JV, et al. Within subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem. 2007;44(Pt 4):343–352.
  • Braga F, Dolci A, Montagnana M, et al. Revaluation of biological variability of glycated hemoglobin using an accurately designed protocol and an assay traceable to the IFCC reference system. Clin Chim Acta. 2011;412(15–16):1412–1416.
  • Goodall I, Colman PG, Schneider HG, et al. Desirable performance standards for A1c analysis – precision, accuracy and standardisation. Clin Chem Lab Med. 2007;45:1083–1097.
  • Weykamp C, John G, Gillery P, IFCC Task Force on Implementation of HbA1c Standardization, et al. Investigation of 2 models to set and evaluate quality targets for Hb A1c: biological variation and Sigma-Metrics. Clin Chem. 2015;61(5):752–759.
  • Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9–17.
  • Heinemann L, Freckmann G. Quality of HbA1c measurement in the practice. J Diabetes Sci Technol. 2015;9(3):687–695.
  • Rodriguez-Segade S, Garcia JR, García-López JM, et al. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status. Clin Chem. 2016;62(12):1570–1578.
  • Urrechaga E. Influence of iron deficiency on Hb A1c levels in type 2 diabetic patients. Diab Met Syndr: Clin Res Rev. 2018;12(6):1051–1055.
  • Rohlfing C, Hanson S, Estey MP, et al. Evaluation of interference from hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by fifteen methods. Clin Chim Acta. 2021;522:31–35.
  • Weykamp CW, Penders TJ, Siebelder CWM, et al. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography and enzyme immunoassay immunoassay. Clin Chem. 1993;39(1):138–142.
  • Szymezak J, Lavalard E, Martin M, et al. Carbamylated hemoglobin remains a critical issue in HbA1c measurements. Clin Chem Lab Med. 2009;47(5):612–613.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.